rs1801159
| Orientation | minus | 
| Stabilized | minus | 
| Geno | Mag | Summary | 
|---|---|---|
| (A;A) | 0 | common in clinvar | 
| (T;T) | 0 | 
| Make rs1801159(A;G) | 
| Make rs1801159(G;G) | 
| Reference | GRCh38 38.1/141 | 
| Chromosome | 1 | 
| Position | 97515839 | 
| Gene | DPYD | 
| is a | snp | 
| is | mentioned by | 
| dbSNP | rs1801159 | 
| dbSNP (classic) | rs1801159 | 
| ClinGen | rs1801159 | 
| ebi | rs1801159 | 
| HLI | rs1801159 | 
| Exac | rs1801159 | 
| Gnomad | rs1801159 | 
| Varsome | rs1801159 | 
| LitVar | rs1801159 | 
| Map | rs1801159 | 
| PheGenI | rs1801159 | 
| Biobank | rs1801159 | 
| 1000 genomes | rs1801159 | 
| hgdp | rs1801159 | 
| ensembl | rs1801159 | 
| geneview | rs1801159 | 
| scholar | rs1801159 | 
| rs1801159 | |
| pharmgkb | rs1801159 | 
| gwascentral | rs1801159 | 
| openSNP | rs1801159 | 
| 23andMe | rs1801159 | 
| SNPshot | rs1801159 | 
| SNPdbe | rs1801159 | 
| MSV3d | rs1801159 | 
| GWAS Ctlg | rs1801159 | 
| GMAF | 0.2048 | 
| Max Magnitude | 0 | 
| ? | (A;A) (A;G) (G;G) | 28 | 
|---|---|---|
| 
 
 | ||
[PMID 19104657 ] Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.
] Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.
[PMID 21362212] [Detection of single nucleotide polymorphisms of mthfr and dpyd genes in leukemia cell lines K562 and K562/A02].
[PMID 25027354 ] [Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines].
] [Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines].
[PMID 23988873 ] [Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing].
] [Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing].
[PMID 23942539] [Potential of dihydropyrimidine dehydrogenase genotypes in personalizing 5-fluorouracil therapy among colorectal cancer patients].
| ClinVar | |
|---|---|
| Risk | rs1801159(G;G) | 
| Alt | rs1801159(G;G) | 
| Reference | Rs1801159(A;A) | 
| Significance | Probable-non-pathogenic | 
| Disease | not provided not specified Dihydropyrimidine dehydrogenase deficiency | 
| Variation | info | 
| Gene | DPYD | 
| CLNDBN | not provided not specified Dihydropyrimidine dehydrogenase deficiency | 
| Reversed | 1 | 
| HGVS | NC_000001.10:g.97981395T>C | 
| CLNSRC | UniProtKB (protein) | 
| CLNACC | RCV000086475.1, RCV000174446.2, RCV000389596.1, | 
[PMID 29372689] DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia.


